Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BNY).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Europe Pre-Open: Futures FTSE (0.21%), DAX (0.31%), CAC40 (0.25%)

Jun 17 ,2026

  • Synopsis

    • European equity markets are set for a softer open amidst mixed Asian equities in quiet Wednesday trade. Taiwan underperforming with semis taking cues from overnight weakness in US. South Korea unchanged with memory majors mixed. Japan outperforming while Greater China little changed. S&P 500 futures nudging higher afterhours

    • In central banks, Riksbank interest rate decision at 9:30CET, press conf at 11:00. Benchmark interest rate expected to be left unchanged at 1.75%. ECB's Cipollone in fireside chat at 9:00CET and panellist at 9:30 at Salzburg Global Finance Forum. Bundesbank's Balz press conf at 10:00CET title: "Payment behavior in Germany 2025" ahead of related press release at 12noon. BOE's Mills panellist at 9:30BST at the Futures industry Assn international derivatives expo. Netherland central bank's Sleijpens speech at European Economics & Financial Center.

    • SECO releases latest economic forecast. IEA oil market report, due to ongoing conflict in the Middle East, the Supply/demand forecasts will be extended to 2027 and the publication of the Market Report - Oil 2026 - Analysis and forecast to 2031 - has been postponed to a later date.

    • Following UK MPs questions on Wales, weekly PMQs gets underway at 12noon BST, whilst committee topics include managing the future of UK oil and gas and work of the Sec. of State for Transport both at 9:15, social and economic impact of the gambling industry at 10:00, regulation of the consumer insurance market at 11:00, HM Treasury and the economics of climate and nature at 14:30.

    • Macro data due include Eurozone May final CPI, UK May CPI, RPI, input/output PPI, Austria May final CPI and Ireland Apr trade balance

    • In earnings, Straumann Holding (STMN.SW) raises its FY26 profitability guidance and increases expected FY26 core EBIT margin expansion from 30 to 60 bps to 140 to 170 bps. Meanwhile, BMW (BMW.GR) shares expected to come under pressure after cutting FY26 guidance and AUTO1 Group (AG1.GR) released long-term targets for Merchant and Retail and confirmed FY26 guidance in connection with its CMD. Colruyt Group (COLR.BB) reported FY results.

  • Politics/Macro/World News

    • French central bank cuts economic growth outlook as energy prices bite - Reuters

    • EU readies trade relief for Armenia after Russian import bans - FT

    • Details of US-Iran 14-point MoU revealed - Bloomberg

  • Top company news

    • Earnings/updates

      • Benelux:

        • COLR.BB (Colruyt Group) -- reports FY net income €304M vs FactSet €299.2M [7 est, €263.6-341M]

      • DACHs:

        • BMW.GR (Bayerische Motoren Werke) -- adjusts FY26 guidance downward; additional measures will have one-time negative impact in H2

        • STMN.SW (Straumann Holding) -- raises its FY26 profitability; increases its expected FY26 core EBIT margin expansion from 30 to 60 bps to 140 to 170 bps

        • AG1.GR (AUTO1 Group) -- reveals long-term targets for Merchant and Retail; confirms FY26 guidance -- CMD

        • KTCG.AV (Kapsch TrafficCom) -- confirms prelim FY results; FY27 revenue and EBIT expected to exceed 2025/26 levels

      • France:

        • MEDCL.FP (MedinCell) -- reports FY net income (€31.3M) vs year-ago (€18.4M)

    • M&A

      • ACOMO.NA (Acomo) -- acquires Spanish family-owned company Citromil; price not disclosed

      • FRVIA.FP (Forvia) -- EU sets a provisional deadline of 27-Jul to rule on Apollo Funds' purchase of Forvia's Interiors group

      • UCB.BB (UCB) -- completes acquisition of Candid Therapeutics

      • ADKO.AV (Addiko Bank) -- Nova Ljubljanska intends to raise offer for Addiko Bank to €37/share

      • VAIAS.FH (Vaisala) -- acquires AI weather company Atmo, Inc. for $70M through combination of cash and shares

      • WBS (Webster Financial) -- Santander Bank and Webster Bank receive OCC approval for previously announced merger - 8-K

      • VOW3.GR (Volkswagen) -- demanding sealed bids in Everllence sale amid fears of conflicts of interest after EQT teamed up with major shareholders - FT

      • MTRS.SS (Munters Group) -- to explore a potential divestment of its FoodTech business area

      • PEN.NO (Panoro Energy) -- completes acquisition of Kosmos Energy subsidiary; deal was announced 24-Feb

      • WHATS.BB (What's Cooking Group) -- shareholders to vote at an EGM on 6-Aug on potential extraordinary (interim) dividend in the offer price

      • CVC DIF emerges as potential bidder for Ausgrid's Plus ES - The Australian

    • Healthcare

      • SEDANA.SS (Sedana Medical) -- submits new drug application to the U.S. FDA for inhaled sedation in the ICU

      • GSK.LN (GSK Plc) --

        • Health Canada approves two new indications for Exdensur, severe asthma and CRSwNP (earlier, 12:13ET)

        • NICE recommends GSK's Nucala for maintenance treatment of uncontrolled COPD with raised blood eosinophils

      • NOVO.B.DC (Novo Nordisk) -- Cyber extortion group FulcrumSec claims to have hacked Novo Nordisk and is exploring selling data - Reuter

      • KURN.SW (Kuros Biosciences) -- hosts its CMD today

    • Other

      • IBAB.BB (Ion Beam Applications) -- announces management changes; appoints Catherine Vandenborre as Chief Ventures & Corporate Officer

      • NCC.A.SS (NCC) -- signs agreement with LKAB for next phase of construction of new sorting plant in Gällivare; order value ~ SEK 900M

      • SKA.B.SS (Skanska) -- awarded building contract worth SEK4.3B ($454M) for the New Jersey Surface Alignment Project in New Jersey

      • ABI.BB (Anheuser-Busch InBev) -- selects Dirk Van de Put, Independent Director since April 2023, as its new Chairman, effective 16-Jun-26

      • EL.FP (EssilorLuxottica) -- and Applied Materials announce long-term joint development agreement to advance augmented reality optics platforms for smart glasses

      • ATS.AV (AT & S Austria Technologie & Systemtechnik) -- AT&S announces reference share price and conversion price of new deeply subordinated perpetual convertible bond

      • NOKIA.FH (Nokia) -- announces major expansion of U.S. semiconductor advanced test and packaging in Pennsylvania to bolster AI growth

      • STMPA.FP (STMicroelectronics) -- prices a $1.5B dual-tranche offering of new convertible bonds

      • EQNR.NO (Equinor) -- Transcript Intelligence: Equinor Capital Markets Day

      • DHL.GR (DHL Group) -- targets 5X increase in energy transition-related revenue by 2030

      • LISN.SW (Chocoladefabriken Lindt & Spruengli) -- now sources 100% of its cocoa as Rainforest Alliance Certified

      • GTT.FP (Gaztransport & Technigaz) -- GTT main terms and conditions of the share buy-back programme

      • KEMIRA.FH (Kemira) -- completes previously announced share buyback program

      • SAGA.B.SS (Sagax) -- completes 30M Class D share issue at SEK33.50/share to raise SEK1.01B

      • RBC Capital Markets names top U.S. picks within Retailing, CPG and Sporting Goods

      • Regional Gaming Revenues - New Jersey May 2026

  • Key rating changes

    • Upgrades

      • WEIR.LN (Weir Group) -- buy from hold at Kepler Cheuvreux

      • ACX.SM (Acerinox) -- buy from neutral at CaixaBank

      • BNP Paribas Exane upgrades TLX.GR; downgrades SCR.FP

      • LNZ.AV (Lenzing) -- to buy from hold at Berenberg

    • Downgrades

      • HM.B.SS (H&M Hennes & Mauritz) -- hold from buy at ABG Sundal Collier

      • ZEAL.DC (Zealand Pharma) -- to hold from buy at Berenberg

    • Other Actions

      • BOY.LN (Bodycote) -- reinstated sector perform at RBC Capital Markets; prior rating was sector perform

  • Data

    • Nikkei +0.88% to 70017.60

    • Hang Seng (0.64%) to 24336.74

    • Shanghai Composite +0.06% to 4094.28

    • S&P futures +19.8 vs prior close of 7587.3

    • €-$ +0.0004 or +0.03% to 1.1613

    • $-¥ (0.11) or (0.07%) to 160.33

    • €-¥ (0.11) or (0.06%) to 186.16

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE

    • BNY.com Terms of Use Privacy Cookie Notice Manage Cookies Disclaimer CUSIP Disclaimer

    • ©  2025 The Bank of New York Corporation. Depositary Receipt business and services are conducted through The Bank of New York.